The KRASG12C inhibitors in lung cancer therapy

Introduction: Lung cancer is characterized by the highest mortality among cancers and is the second most frequently diagnosed type of cancer in the world. Targeted therapies are a promising therapeutic option for patients with this disease, however, one of the most common and most malignant mutations (KRAS) remains a challenge. Purpose: The aim of this study is to bring closer the problem of the KRAS mutation, in particular KRASG12C, and to present the most important information about the compounds created for therapies targeted at it.For a better understanding of the issue, the study contains information about the mechanisms of both mutation and drugs, as well as the most important statistical data and research results. Materials and methods: The review was based on articles available in the PubMed database. Conclusions: Two drugs targeting KRASG12C (sotorasib and adagrasib) have proven their clinical effectiveness and represent a milestone in the development of targeted therapies for lung cancer with this mutation. However, they are not without side effects, and the emerging resistance and presence of commutations that reduce drug potency continue to challenge the scientific community. Research is underway to refine therapies using existing inhibitors as well as to develop further compounds targeting KRASG12C

Seborrheic dermatitis - pathogenesis, epidemiology and effective treatment - literature review

Introduction: Seborrheic dermatitis (SD) is common inflammatory dermatology disease. It’s affect up to 3-8% of the population. SD is characterized by erythema yellowish plaques and different level of itching and scaling. The last two symptoms are important factors that affect the quality of life of patients. This condition is usually a reaction to growth of  Malassezia spp and commonly develop in regions of strong sebaceous glands such as the scalp, facial area, chest, back. Other factors include increased activity of sebaceous glands, immunosuppression, and stress. Aim of the study: A review of current stage of knowledge on the pathophysiology, epidemiology of Seborrheic Dermatitis. Recommended management with newest guidelines of this disease. The impact of the Covid-19 pandemic and the use of masks on the incidence of Seborrheic Dermatitis. Material and methods: This review was based on available data searched in the PubMed and Google Scholar by using key words: Seborrheic dermatitis, pathophysiology, epidemiology, diagnosis, treatment, clinical presentation, scalp, infant.  Conclusion: The Pathogenesis of Seborrheic dermatitis is not fully understood, the exact molecular process needs to be examined. SD is chronic disease with episode of remission and relapse of symptoms. Patients should be informed that ongoing maintenance treatment will be required. Treatment include topical antifungal (ketoconazole, Ciclopirox olamine, zinc pyrithione) and topical anti-inflammatory drugs like mild or mid-strength corticosteroids or calcineurin inhibitors (off-label use). In severe or resistance cases systematic therapy could be necessary. In this situation antifungal drugs (terbinafine, itraconazole) or low dose of isotretinoin are available options. Also new synergic treatments were introduce like cannabinoids or vitamin D which could make therapy more efficiency

FDA Approves Omaveloxolone based on Successful Moxie Trial Results for Friedreich's Ataxia - Review

Introduction: In recent years, the medical community has witnessed a significant breakthrough in the treatment of Friedreich's Ataxia (FRDA), a rare and debilitating genetic disorder affecting the nervous system. This neurological condition, characterized by progressive muscle weakness, impaired coordination, and cardiomyopathy, has long posed challenges for both patients and healthcare professionals alike. However, there is newfound hope with the recent approval of Omaveloxolone by the U.S. Food and Drug Administration (FDA).Aim of the study: This review article aims to present a detailed summary of the FDA's approval of Omaveloxolone as a therapeutic option for Friedreich's Ataxia (FRDA), focusing on the positive results obtained from the MOXIe trial. It covers various aspects of FRDA and explains how Omaveloxolone works as an activator of NRF2, a transcription factor that helps reduce oxidative stress. The MOXIe trial, which examined the safety and effectiveness of Omaveloxolone in FRDA patients, is discussed in detail, including its methodology, primary and secondary goals, and results. Materials and methods: This review was based on available data collected in the PubMed and Google Scholar database, using the key words: FRDA, Friedreich’s Ataxia, Omaveloxolone, RTA 408, NRF2, MOXIe trail.Conclusion: Omaveloxolone has shown significant efficacy in improving neurological function and mFARS scores compared to a placebo in the MOXIe trial. It is well-tolerated with minimal adverse events. Early intervention with Omaveloxolone offers enhanced benefits for managing Friedreich's ataxia progression

Pruritus. Pathomechanism, management and novel treatment

Introduction Itching is an unpleasant sensation that is commonly experienced in the general population. It accompanies many diseases. This sensory experience is burdensome and significantly reduces the quality of life. The mechanism of itching is complex. It involves receptors, the histaminergic and non-histaminergic pathways, cytokines, neuropeptides, neurotransmitters, proteases, and enzymes. External factors such as temperature or capsaicin also influence itching. Aim of the study This review presents the current state of knowledge regarding therapy in the treatment of itching. Also aims to show that it is a complicated process. Pruritus is a very bothersome sensory sensation and is a common symptom.  Material and methods This review was based on scientific books on human physiology and dermatology were used, which are listed in the bibliography and available data collected in the PubMed and Google Scholar database. Using key words:  itch, management, pathogenesis, pathophysiology, pruritus, therapeutics, treatments. Conclusion The latest research on itching has led to a better understanding of this complex mechanism. As a result, there is a possibility of discovering new, innovative treatment methods that are targeted at specific elements of this process or work systemically. Understanding the broad etiology assists in identifying the cause and in implementing an appropriate therapeutic strategy. Further research will enable improvements in treatment and enhance patient comfort

The role of glymphatic system in neurological diseases - literature review

Abstract  Introduction: The glymphatic system is the equivalent of the lymphatic system in the brain. This system is responsible for the exchange of metabolism waste products between the cerebrospinal fluid and the interstitial fluid. The glymphatic system functions mainly during sleep, and this is when the removal of interstitial metabolism waste products take place. A proper diet and physical activity are also needed for the glymphatic system to work effectively. Abnormal function of the glymphatic system can contribute to the development of diseases of the central nervous system, including neurodegenerative diseases and migraine.  Aim of the study: The aim of our study is to review the latest knowledge linking the glymphatic system with the pathogenesis of selected neurological diseases and other lifestyle-related factors such as sleep, diet and physical activity. The study included Alzheimer’s disease, Parkinson’s disease, migraines and ischemic stroke.  Materials and methods: We have reviewed the literature available in the pubmed database using keywords: “glymphatic system”; “aquaporin-4”; “Alzheimer’s disease”; “Parkinson’s disease”; “migraines”; “sleep”  Conclusions: The studies discussed here show a clear correlation between the glymphatic system and neurological diseases. The glymphatic system may definitely be involved in the pathophysiology of neurological disorders. A thorough investigation of this issue will help uncover potentially new strategies for the prevention and treatment of neurological diseases.    Key words: glymphatic system; aquaporin-4; Alzheimer’s disease; Parkinson’s disease; migraine; sleep

"Granice i pogranicza: państw, grup, dyskursów... : perspektywa antropologiczna i socjologiczna" - recenzja

Praca zbiorowa Granice i pogranicza: państw, grup, dyskursów… Perspektywa antropologiczna i socjologiczna, przygotowana pod redakcją naukową Grażyny Kubicy i Haliny Rusek, zawiera teksty badaczek i badaczy związanych z Sekcją Antropologii Społecznej Polskiego Towarzystwa Socjologicznego. Jak piszą Redaktorki we Wprowadzeniu, intencją autorów była reinterpretacja teorii granic Frederika Bartha w kontekście granic państwowych, kulturowych, granic tworzonych między dyscyplinami, dyskursami, ale i klasami. Opracowanie składa się z trzech części i zawiera szesnaście artykułów, w których autorzy podejmują problematykę granic i pograniczy w szerokim kontekście kultury

Coming Back from International Educational Exchanges – Difficulties, Changes, Challenges

International collaboration in education has resulted in an increasing number of participants in educational exchanges at various stages of education. Taking part in a foreign intercultural exchange is an important experience, associated with a half a year or a year-long immersion in another culture and with the return home. Changing the residence country for a certain period, learners consciously undertake the tasks aimed at familiarization with the new culture, language, customs or behaviours. Few of them think about the difficulties associated with the comeback. The presented research results show that, during the exchange, learners were able to build their strategy of functioning in the host family and country. As a result, this helped them to handle the difficulties of the reverse culture shock, which is manifested by the optimistic-active strategy applied by most of the learners after returning home

Nocturnal paroxysmal dystonia – Case report

Nocturnal paroxysmal dystonia describes a syndrome consisting of recurrent motor episodes of dystonic–dyskinetic features arising from non-rapid eye movement (NREM) sleep. In the article, the authors present female case of nocturnal paroxysmal dystonia. The patient has had attacks since her childhood and was eventually diagnosed at the age of 48. Therapy with carbamazepine considerably reduced the frequency and entent of seizures. The present case evidences that nocturnal paroxysmal dystonia still is a diagnostic challenge for clinicians. Especially, we emphasize the importance of polysomnography in the verification of the diagnosis

The role of glymphatic system in neurological diseases - literature review

Abstract  Introduction: The glymphatic system is the equivalent of the lymphatic system in the brain. This system is responsible for the exchange of metabolism waste products between the cerebrospinal fluid and the interstitial fluid. The glymphatic system functions mainly during sleep, and this is when the removal of interstitial metabolism waste products take place. A proper diet and physical activity are also needed for the glymphatic system to work effectively. Abnormal function of the glymphatic system can contribute to the development of diseases of the central nervous system, including neurodegenerative diseases and migraine.  Aim of the study: The aim of our study is to review the latest knowledge linking the glymphatic system with the pathogenesis of selected neurological diseases and other lifestyle-related factors such as sleep, diet and physical activity. The study included Alzheimer’s disease, Parkinson’s disease, migraines and ischemic stroke.  Materials and methods: We have reviewed the literature available in the pubmed database using keywords: “glymphatic system”; “aquaporin-4”; “Alzheimer’s disease”; “Parkinson’s disease”; “migraines”; “sleep”  Conclusions: The studies discussed here show a clear correlation between the glymphatic system and neurological diseases. The glymphatic system may definitely be involved in the pathophysiology of neurological disorders. A thorough investigation of this issue will help uncover potentially new strategies for the prevention and treatment of neurological diseases.    Key words: glymphatic system; aquaporin-4; Alzheimer’s disease; Parkinson’s disease; migraine; sleep

Pruritus. Pathomechanism, management and novel treatment

Introduction Itching is an unpleasant sensation that is commonly experienced in the general population. It accompanies many diseases. This sensory experience is burdensome and significantly reduces the quality of life. The mechanism of itching is complex. It involves receptors, the histaminergic and non-histaminergic pathways, cytokines, neuropeptides, neurotransmitters, proteases, and enzymes. External factors such as temperature or capsaicin also influence itching. Aim of the study This review presents the current state of knowledge regarding therapy in the treatment of itching. Also aims to show that it is a complicated process. Pruritus is a very bothersome sensory sensation and is a common symptom.  Material and methods This review was based on scientific books on human physiology and dermatology were used, which are listed in the bibliography and available data collected in the PubMed and Google Scholar database. Using key words:  itch, management, pathogenesis, pathophysiology, pruritus, therapeutics, treatments. Conclusion The latest research on itching has led to a better understanding of this complex mechanism. As a result, there is a possibility of discovering new, innovative treatment methods that are targeted at specific elements of this process or work systemically. Understanding the broad etiology assists in identifying the cause and in implementing an appropriate therapeutic strategy. Further research will enable improvements in treatment and enhance patient comfort